Oncology Systems Limited (OSL) is to distribute Heltschl GmbH’s low level laser therapy products in the UK and Ireland. Formed in 1994, Heltschl is a leading supplier of laser therapy devices in Austria and neighbouring countries. Low level laser therapy can be used in almost all areas of medicine, including oncology and radiation therapy, neurology and veterinary medicine.
OSL sales manager Lucy Griffiths said: “Low level laser therapy has been shown to be effective in the treatment of oral mucositis, offering the potential for significant improvement in the quality of life of head and neck patients. At OSL, we’re excited to be able to help increase access to this game-changing treatment to patients across the UK and Ireland.”
A Heltschl spokesperson said: “It’s a great pleasure to have found such an expert and reliable partner in OSL for the distribution of our laser devices in the UK and Ireland in the field of oncology and radiotherapy. It is important for us to have a partner that can offer hospitals and patients the opportunity to provide an efficient form of therapy that reduces the side effects of chemotherapy and radiation therapy.”
Picture: OSL will distribute Heltschl products.
Read this report on page 10 of the January 2025 issue of RAD Magazine.